Literature DB >> 17285349

Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children.

Peter Kan1, John Kestle.   

Abstract

OBJECTIVE: Shunt infection is a common and serious complication of cerebrospinal fluid (CSF) shunting most commonly caused by skin flora contamination at surgery. Recent studies indicate that the use of antibiotic-impregnated (AI) shunt systems may reduce the risk of postoperative shunt infections. We evaluated the incidence of shunt infections associated with the use of AI shunt catheters and compared it with the incidence associated with standard non-AI catheters.
MATERIALS AND METHODS: All shunt procedures performed by one surgeon using AI catheters were reviewed. An equal number of consecutive shunt procedures performed by the same surgeon using non-AI catheters were reviewed from the period immediately before the introduction of the AI system. Patients with <9 months of follow-up were excluded; all shunt infections and shunt-related complications were recorded. The proportions of infected shunts in the AI and control groups were compared using a chi (2) analysis.
CONCLUSION: We reviewed 160 shunt procedures (80 per group). The infection rate was 5.0% among patients with AI catheters compared with 8.8% in the control group (P = 0.534, Fischer's exact). The average time to infection was similar between the two groups. Among the AI group, the shunt infection rate did not differ between ventricular catheter, distal catheter revisions, and revisions of ventricular and peritoneal tubing. In contrast with other reports, we found no significant reduction in the pediatric CSF shunt infection rate with the use of AI shunt systems. Any recommendation for or against the routine use of AI systems in children requires a prospective, blinded, randomized-controlled trial with adequate power.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285349     DOI: 10.1007/s00381-007-0296-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.532


  28 in total

1.  Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus.

Authors:  R J Ignelzi; W M Kirsch
Journal:  J Neurosurg       Date:  1975-06       Impact factor: 5.115

2.  A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections.

Authors:  W Kohnen; J Schäper; O Klein; B Tieke; B Jansen
Journal:  Zentralbl Bakteriol       Date:  1998-01

Review 3.  Shunt infections: prevention and treatment.

Authors:  P H Chapman; L F Borges
Journal:  Clin Neurosurg       Date:  1985

4.  Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience.

Authors:  R George; L Leibrock; M Epstein
Journal:  J Neurosurg       Date:  1979-12       Impact factor: 5.115

5.  In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections.

Authors:  J Hampl; J Schierholz; B Jansen; A Aschoff
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial.

Authors:  John R W Kestle; James M Drake; D Douglas Cochrane; Ruth Milner; Marion L Walker; Rick Abbott; Frederick A Boop
Journal:  J Neurosurg       Date:  2003-02       Impact factor: 5.115

7.  Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome.

Authors:  B C Walters; H J Hoffman; E B Hendrick; R P Humphreys
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

8.  Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.

Authors:  Soma T Govender; Narendra Nathoo; James R van Dellen
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

9.  Infections of central nervous system shunts.

Authors:  P Gardner; T Leipzig; P Phillips
Journal:  Med Clin North Am       Date:  1985-03       Impact factor: 5.456

10.  Ventriculoperitoneal shunt infections in children. A 6-year study.

Authors:  M F Cotton; B Hartzenberg; P R Donald; P J Burger
Journal:  S Afr Med J       Date:  1991-02-02
View more
  24 in total

Review 1.  Strategies to decrease the risk of ventricular catheter infections: a review of the evidence.

Authors:  Maya A Babu; Robin Patel; W Richard Marsh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

Review 2.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

3.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

4.  Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.

Authors:  Scott L Parker; Frank J Attenello; Daniel M Sciubba; Giannina L Garces-Ambrossi; Edward Ahn; Jon Weingart; Benjamin Carson; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-11-05       Impact factor: 1.475

Review 5.  Shunt infections: a review and analysis of a personal series.

Authors:  Santosh Mohan Rao Kanangi; Chidambaram Balasubramaniam
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

6.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

7.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

8.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

9.  Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years.

Authors:  Joon Kee Lee; Joon Young Seok; Joon Ho Lee; Eun Hwa Choi; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Hoan Jong Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

10.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.